Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


12.07.2021

2 Ann Surg Oncol
1 Ann Thorac Surg
3 Anticancer Res
1 BMC Cancer
1 Cancer Lett
2 Cancer Sci
1 Clin Lung Cancer
2 Clin Nucl Med
4 Eur J Cardiothorac Surg
1 Eur Respir J
1 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
1 J Clin Oncol
15 J Thorac Oncol
1 Lancet
1 Lung Cancer
1 Lung Cancer (Auckl)
2 N Engl J Med
4 Oncologist
1 PLoS Comput Biol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
    Ann Surg Oncol. 2021 Jul 3. pii: 10.1245/s10434-021-10020.
    PubMed         Abstract available

  2. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4542-4550.
    PubMed         Abstract available


    Ann Thorac Surg

  3. ROBINSON DP, Smith AE, Okiror L
    Lung Cancer Surgery in the early phase after acute COVID-19 pneumonitis.
    Ann Thorac Surg. 2021 Jul 1. pii: S0003-4975(21)01090.
    PubMed         Abstract available


    Anticancer Res

  4. ZAITSU J, Yamashita Y, Ishikawa A, Saito A, et al
    Systemic Inflammatory Score Predicts Response and Prognosis in Patients With Lung Cancer Treated With Immunotherapy.
    Anticancer Res. 2021;41:3673-3682.
    PubMed         Abstract available

  5. SHIONOYA Y, Hirohashi Y, Takahashi H, Hashimoto M, et al
    Possible Pseudo-progression of Non-small Cell Lung Carcinoma in a Patient With Clinical Hyper-progression Associated With Trousseau Syndrome Who Was Treated With Pembrolizumab: A Case Report.
    Anticancer Res. 2021;41:3699-3706.
    PubMed         Abstract available

  6. JANG SK, Hong SE, Lee DH, Kim JY, et al
    Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin.
    Anticancer Res. 2021;41:3481-3487.
    PubMed         Abstract available


    BMC Cancer

  7. LIU T, Luo H, Zhang J, Hu X, et al
    Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
    BMC Cancer. 2021;21:783.
    PubMed         Abstract available


    Cancer Lett

  8. HUANG J, Tian F, Song Y, Cao M, et al
    A feedback circuit comprising EHD1 and 14-3-3zeta sustains beta-catenin/c-Myc-mediated aerobic glycolysis and proliferation in non-small cell lung cancer.
    Cancer Lett. 2021;520:12-25.
    PubMed         Abstract available


    Cancer Sci

  9. WANG S, Cai J, Zhang S, Dong M, et al
    Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis.
    Cancer Sci. 2021 May 1. doi: 10.1111/cas.14920.
    PubMed         Abstract available

  10. SHI H, Niimi A, Takeuchi T, Shiogama K, et al
    CEBPgamma facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.
    Cancer Sci. 2021;112:2770-2780.
    PubMed         Abstract available


    Clin Lung Cancer

  11. GADGEEL S, Hirsch FR, Kerr K, Barlesi F, et al
    Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK Trial.
    Clin Lung Cancer. 2021 May 30. pii: S1525-7304(21)00101.
    PubMed         Abstract available


    Clin Nucl Med

  12. TOSI D, Pieropan S, Cattoni M, Bonitta G, et al
    Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients.
    Clin Nucl Med. 2021 May 26. pii: 00003072-900000000-96017.
    PubMed         Abstract available

  13. LI C, Tian Y, Chen J, Wen B, et al
    An Unusual Case of Esophageal Carcinosarcoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2021 Jan 28. pii: 00003072-900000000-96223.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  14. MARIANI AW, Vallilo CC, de Albuquerque ALP, Salge JM, et al
    Preoperative evaluation for lung resection in patients with bronchiectasis: should we rely on standard lung function evaluation?
    Eur J Cardiothorac Surg. 2021;59:1272-1278.
    PubMed         Abstract available

  15. SHEN H, Wang X, Nie Y, Zhang K, et al
    Minimally invasive surgery versus thoracotomy for resectable stage II and III non-small-cell lung cancers: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2021;59:940-950.
    PubMed         Abstract available

  16. ZHAO M, Deng J, Wang T, Li Y, et al
    Impact of computed tomography window settings on clinical T classifications and prognostic evaluation of patients with subsolid nodules.
    Eur J Cardiothorac Surg. 2021;59:1295-1303.
    PubMed         Abstract available

  17. GONZALEZ M, Brunelli A, Szanto Z, Passani S, et al
    Report from the European Society of Thoracic Surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy.
    Eur J Cardiothorac Surg. 2021;59:996-1003.
    PubMed         Abstract available


    Eur Respir J

  18. CHERNBUMROONG S, Johnson J, Gupta N, Miller S, et al
    Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
    Eur Respir J. 2021;57.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  19. QIU B, Wang D, Li Q, Wu Y, et al
    Concurrent chemoradiotherapy with or without nimotuzumab in locally advanced squamous cell lung cancer: a phase 2 randomized trial.
    Int J Radiat Oncol Biol Phys. 2021 Jul 3. pii: S0360-3016(21)00824.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  20. GUO R, Zhang Y, Ma Z, Deng C, et al
    Overuse of follow-up chest computed tomography in patients with incidentally identified nodules suspicious for lung cancer.
    J Cancer Res Clin Oncol. 2021 Jul 8. pii: 10.1007/s00432-021-03692.
    PubMed         Abstract available

  21. IANZA A, Di Chicco A, Biagi C, Giudici F, et al
    EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience.
    J Cancer Res Clin Oncol. 2021;147:2301-2307.
    PubMed         Abstract available


    J Clin Oncol

  22. PASSIGLIA F, Cinquini M, Bertolaccini L, Del Re M, et al
    Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2021 Jun 2:JCO2002574. doi: 10.1200/JCO.20.02574.
    PubMed         Abstract available


    J Thorac Oncol

  23. STEUER CE, Jegede OA, Dahlberg SE, Wakelee HA, et al
    Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
    J Thorac Oncol. 2021;16:960-967.
    PubMed         Abstract available

  24. FINN SP, Addeo A, Dafni U, Thunnissen E, et al
    Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project.
    J Thorac Oncol. 2021;16:990-1002.
    PubMed         Abstract available

  25. CAMIDGE DR, Otterson GA, Clark JW, Ignatius Ou SH, et al
    Crizotinib in Patients With MET-Amplified NSCLC.
    J Thorac Oncol. 2021;16:1017-1029.
    PubMed         Abstract available

  26. WARREN GW, Evans WK, Dresler C
    Critical Determinants of Cancer Treatment Outcomes: Smoking Must Be Addressed at the Highest Levels in Cancer Care.
    J Thorac Oncol. 2021;16:891-893.
    PubMed        

  27. BAUMAN J, Borghaei H
    To Give or Not to Give: Consolidative Durvalumab in EGFR-Mutant NSCLC.
    J Thorac Oncol. 2021;16:894-896.
    PubMed        

  28. DEUTSCH E, Cengel KA, Galluzzi L, Levy A, et al
    Could Protons Promote Tumor Control by Avoiding Lymphopenia?
    J Thorac Oncol. 2021;16:e39-e41.
    PubMed        

  29. HANN CL, Burns TF, Dowlati A, Morgensztern D, et al
    Brief Report: A Phase 1 Study Evaluating Rovalpituzumab Tesirine (Rova-T) in Frontline Treatment of Patients With Extensive-Stage Small Cell Lung Cancer.
    J Thorac Oncol. 2021 Jul 6. pii: S1556-0864(21)02289.
    PubMed         Abstract available

  30. PARK HR, Kim TM, Lee Y, Kim S, et al
    Acquired resistance to third-generation EGFR tyrosine kinase inhibitors in patients with de novo EGFR(T790M)-mutant non-small cell lung cancer.
    J Thorac Oncol. 2021 Jul 6. pii: S1556-0864(21)02254.
    PubMed         Abstract available

  31. KUMAR A, Kumar S, Gilja S, Potter A, et al
    Reconsidering the American Joint Committee on Cancer 8(th) Edition TNM Staging Manual Classifications for T2b/T3 Non-small-cell Lung Cancer.
    J Thorac Oncol. 2021 Jul 6. pii: S1556-0864(21)02283.
    PubMed         Abstract available

  32. GRASS GD, Scott JG, Sedor G, Kattan MW, et al
    Response to: Noncancer Cells in Tumor Samples May Bias the Predictive Genomically Adjusted Radiation Dose.
    J Thorac Oncol. 2021;16:e48-e49.
    PubMed        

  33. DU Y, Hu Z, Liang J, Zhan C, et al
    Noncancer Cells in Tumor Samples May Bias the Predictive Genomic-Adjusted Radiation Dose.
    J Thorac Oncol. 2021;16:e47.
    PubMed        

  34. RYAN BM
    In Response: Using Propensity Score Matching to Balance the Baseline Characteristics.
    J Thorac Oncol. 2021;16:e46.
    PubMed        

  35. LIANG J, Hu Z, Zhan C, Wang Q, et al
    Using Propensity Score Matching to Balance the Baseline Characteristics.
    J Thorac Oncol. 2021;16:e45-e46.
    PubMed        

  36. BELDERBOS JSA, De Ruysscher DKM, De Jaeger K, Koppe F, et al
    Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?
    J Thorac Oncol. 2021;16:e42-e45.
    PubMed        

  37. BREEN WG, Brown PD, Laack NN
    Hippocampal Avoidance Prophylactic Cranial Irradiation for SCLC.
    J Thorac Oncol. 2021;16:e41-e42.
    PubMed        


    Lancet

  38. TREASURE T, Macbeth F, Farewell V, Williams NR, et al
    The fallacy of large survival gains from lung metastasectomy in colorectal cancer.
    Lancet. 2021;397:97-98.
    PubMed        


    Lung Cancer

  39. LAVOLE A, Mazieres J, Schneider S, Brosseau S, et al
    Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial.
    Lung Cancer. 2021;158:146-150.
    PubMed         Abstract available


    Lung Cancer (Auckl)

  40. SHUKLA N, Hanna N
    Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer.
    Lung Cancer (Auckl). 2021;12:51-60.
    PubMed         Abstract available


    N Engl J Med

  41. AWAD MM, Liu S, Rybkin II, Arbour KC, et al
    Acquired Resistance to KRAS(G12C) Inhibition in Cancer.
    N Engl J Med. 2021;384:2382-2393.
    PubMed         Abstract available

  42. SKOULIDIS F, Li BT, Dy GK, Price TJ, et al
    Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
    N Engl J Med. 2021;384:2371-2381.
    PubMed         Abstract available


    Oncologist

  43. LOI M, Alifano M, Scorsetti M, Nuyttens JJ, et al
    Judging a Fish by Its Ability to Climb a Tree? A Call for Novel Endpoints in the Appraisal of Ablative Local Treatments of Oligometastatic Cancer.
    Oncologist. 2021;26:e1085-e1086.
    PubMed        

  44. ALKREKSHI A, Tamaskar I
    Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection.
    Oncologist. 2021;26:e827-e830.
    PubMed         Abstract available

  45. VARLOTTO JM, Sun Z, Ky B, Upshaw J, et al
    A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study.
    Oncologist. 2021;26:523-532.
    PubMed         Abstract available

  46. MIYAGAWA C, Takaya H, Sakai K, Nishio K, et al
    A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review.
    Oncologist. 2021;26:356-361.
    PubMed         Abstract available


    PLoS Comput Biol

  47. GONCALVES IG, Garcia-Aznar JM
    Extracellular matrix density regulates the formation of tumour spheroids through cell migration.
    PLoS Comput Biol. 2021;17:e1008764.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: